Evidence map›Paper›PMID 33495292›Full record

ArticleDiabetes care2021

Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes.

Claire L Meek, Diana Tundidor, Denice S Feig, Jennifer M Yamamoto, Eleanor M Scott, Diane D Ma, Jose A Halperin, Helen R Murphy, Rosa Corcoy, CONCEPTT Collaborative Group

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Trial
  4. Trial
  5. Continuous Glucose Monitoring Time-in-Range and HbADiabetes technology & therapeutics · 2021
    Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Review
  20. Roadmap to the Effective Use of Continuous Glucose Monitoring in Pregnancy.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 4 countries.

Claire L MeekWellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, U.K. clm70@cam.ac.uk corcoy@santpau.cat.ORCID 0000-0002-4176-8329
Diana TundidorInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Denice S FeigMount Sinai Hospital, Sinai Health System, Department of Medicine, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada.
Jennifer M YamamotoDepartment of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Eleanor M ScottLeeds Institute of Cardiovascular and Metabolic Medicine, Leeds Centre for Diabetes and Endocrinology, University of Leeds, Leeds, U.K.ORCID 0000-0001-5395-8261
Diane D MaLaboratory for Translational Research, Harvard Medical School, Brigham and Women's Hospital, Boston, MA.
Jose A HalperinLaboratory for Translational Research, Harvard Medical School, Brigham and Women's Hospital, Boston, MA.
Helen R MurphyNorwich Medical School, University of East Anglia, Norwich, U.K.ORCID 0000-0001-6876-8727
CONCEPTT Collaborative Group
Brigham and Women's Hospital · USUniversitat Autònoma de Barcelona · ESCambridge University Hospitals NHS Foundation Trust · GBMount Sinai Hospital · CAUniversity of Calgary · CAUniversity of East Anglia · GBUniversity of Leeds · GB

Funding

Blood Levels of Glycated CD59, a Novel Biomarker to Assess Pregnancy-induced Glucose IntoleranceR01DK118528 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI HALPERIN, JOSE A · 2019 to 2023
$3.5M
Department of Health CDF-2013-06-035NIDDK NIH HHS R01 DK118528
6 · The paper itself

Abstract

objectiveThe optimal method of monitoring glycemia in pregnant women with type 1 diabetes remains controversial. This study aimed to assess the predictive performance of HbA RESEARCH DESIGN AND

methodsOne hundred fifty-seven women from the Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial (CONCEPTT) were included in this prespecified secondary analysis. HbA

resultsHbA

conclusionsHbA

Indexed as

Diabetes Mellitus, Type 1BiomarkersBlood GlucoseBlood Glucose Self-MonitoringFemaleGlycated HemoglobinHumansInfant, NewbornPregnancyPregnancy OutcomeBiomarkersBlood GlucoseGlycated Hemoglobin

Identifiers

PMID33495292
PMCPMC8051277
OpenAlexW3122441823

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.